Vanguard Group Inc Heron Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 8,471,460 shares of HRTX stock, worth $11.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,471,460

Previous 8,225,585 2.99%

Holding current value

$11.1 Million

Previous $18.1 Million 3.1%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$1.72 - $2.42 $422,905 - $595,017	245,875 Added 2.99%	8,471,460 $17.5 Million
Q1 2025 May 09, 2025	BUY	$1.47 - $2.55 $99,924 - $173,338	67,976 Added 0.83%	8,225,585 $18.1 Million
Q4 2024 Feb 11, 2025	SELL	$1.06 - $2.12 $596,321 - $1.19 Million	-562,567 Reduced 6.45%	8,157,609 $12.5 Million
Q3 2024 Nov 13, 2024	BUY	$1.73 - $3.67 $180,359 - $382,612	104,254 Added 1.21%	8,720,176 $17.4 Million
Q2 2024 Aug 13, 2024	BUY	$2.32 - $3.86 $1.16 Million - $1.93 Million	501,206 Added 6.18%	8,615,922 $30.2 Million
Q1 2024 May 10, 2024	SELL	$1.71 - $3.06 $383,375 - $686,039	-224,196 Reduced 2.69%	8,114,716 $22.5 Million
Q4 2023 Feb 14, 2024	BUY	$0.54 - $1.82 $91,601 - $308,730	169,632 Added 2.08%	8,338,912 $14.2 Million
Q3 2023 Nov 14, 2023	BUY	$0.97 - $1.8 $27,701 - $51,404	28,558 Added 0.35%	8,169,280 $8.41 Million
Q2 2023 Aug 14, 2023	SELL	$1.11 - $2.88 $321,784 - $834,900	-289,896 Reduced 3.44%	8,140,722 $9.44 Million
Q1 2023 May 15, 2023	BUY	$1.51 - $3.25 $942,742 - $2.03 Million	624,333 Added 8.0%	8,430,618 $12.7 Million
Q4 2022 Feb 10, 2023	SELL	$2.25 - $4.67 $2.13 Million - $4.42 Million	-946,556 Reduced 10.81%	7,806,285 $19.5 Million
Q3 2022 Nov 14, 2022	BUY	$2.66 - $5.37 $2.1 Million - $4.25 Million	790,644 Added 9.93%	8,752,841 $36.9 Million
Q2 2022 Aug 12, 2022	SELL	$2.3 - $6.29 $4.54 Million - $12.4 Million	-1,972,491 Reduced 19.85%	7,962,197 $22.2 Million
Q1 2022 May 13, 2022	BUY	$4.63 - $9.94 $1.51 Million - $3.24 Million	325,643 Added 3.39%	9,934,688 $56.8 Million
Q4 2021 Feb 14, 2022	BUY	$8.35 - $12.6 $908,087 - $1.37 Million	108,753 Added 1.14%	9,609,045 $87.7 Million
Q3 2021 Nov 12, 2021	BUY	$10.13 - $15.0 $1.83 Million - $2.71 Million	180,564 Added 1.94%	9,500,292 $102 Million
Q2 2021 Aug 13, 2021	BUY	$13.27 - $18.48 $124 Million - $172 Million	9,319,728 New	9,319,728 $145 Million

Others Institutions Holding HRTX

# of Institutions

185

Shares Held

130M

Call Options Held

1.56M

Put Options Held

27.1K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $156M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Heron Therapeutics, Inc. Transaction History